Greater Bailtimore Medical Center Home
Contact Us About GBMC GBMC Online Bill Pay Map & Directions Donate
Head and Neck Home
Ask an Expert Head & Neck Our Team Contact Head & Neck Center
PrintSpacerEmail
Decrease (-) Restore Default Increase (+) Font Size

Clinical Trials Search

Search ALL Clinical Trials at GBMC 
 

Oncology-Head and Neck 

Title Study Number Trial Type Condition Trial Status Principal Investigator
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Center R0920  Oncology-Head and Neck    Open to Accrual  Marshall Levine¸ MD 
A Phase II, Open-Label, Randomized Study of MEHD7945A Versus Cetuximab in Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck Who Have Progressed During or Following Platinum-Based Chemotherapy CC1205  Oncology-Head and Neck    Open to Accrual  Marshall Levine¸ MD 
A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab In Patients with Recurrent Or Metastatic Head and Neck Cancer
 		E1305  Oncology-Head and Neck    Open to Accrual  Marshall Levine¸ MD 
A Retrospective Review of Chemoradiation Treatment Protocols for Head and Neck Cancer Patients. HN1001  Oncology-Head and Neck    Open to Accrual  Patrick Ha¸ MD 
Non·Oropharyngeal Robotic Surgery for Head and Neck Lesions
 		NORS/BLANCO  Oncology-Head and Neck    Open to Accrual  Ray Gervacio F. Blanco¸ MD 
Detection of Genetic Alterations in Head and Neck Tumors. HN0801  Oncology-Head and Neck  -  Open to Accrual  Joseph Califano¸ MD 
Molecular Surveillance for Head and Neck Cancer. HN0902  Oncology-Head and Neck  -  Open to Accrual  Joseph Califano¸ MD 
Collection of Waste Tissue from Surgically Resected Human Head and Neck Neoplasms for Xenografting in Athymic or SCID Mice. HN0701  Oncology-Head and Neck  -  Open to Accrual  Patrick Ha¸ MD 
Submental and transoral ultrasound for evaluation of Orpharyngeal and Oral Cavity Anatomy, Speech and Swallowing Function in Cases and Controls. DC1004  Oncology-Head and Neck  -  Open to Accrual  Ray Gervacio F. Blanco¸ MD 
Evaluation of Immunologic Responses against the Flu Vaccine in Head and Neck Cancer Patients after Completing Chemoradiation Therapy. HN1101  Oncology-Head and Neck  -  Open to Accrual  Sara Pai¸ MD¸ PhD 
Monitoring of Immunologic Function Following Chemoradiation Therapy in Head and Neck Cancer Patients. HN0802  Oncology-Head and Neck  -  Open to Accrual  Sara Pai¸ MD¸ PhD 
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma R1010  Oncology-Head and Neck  Esophageal  Open to Accrual  Marshall Levine¸ MD 
A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
R1008  Oncology-Head and Neck  Salivary Gland  Open to Accrual  Marshall Levine¸ MD 
An Open-Label, Multi-Center Phase II Study of the BRAF Inhibitor RO5185426 in Patients with Metaststic or Unresectable Papillary Thyroid Cancer (PTC) positive for the BRAF V600 Mutation and Resistant to Radioactive Iodine JHCRN-J1150  Oncology-Head and Neck  Thyroid  Open to Accrual  Mei Tang¸ MD